NICOLE GALATI: Open Payments
NPI 1174204093 · SEWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,904 in 236 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,647 · 2025 $3,904
Food & beverage: $3,904
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 77 | $1,127 |
| AstraZeneca Pharmaceuticals LP | 19 | $440 |
| Regeneron Healthcare Solutions, Inc. | 25 | $340 |
| Verona Pharma, Inc. | 18 | $257 |
| GENZYME CORPORATION | 12 | $197 |
| Lilly USA, LLC | 5 | $183 |
| Amgen Inc. | 14 | $181 |
| ANI Pharmaceuticals, Inc. | 9 | $161 |
| HARMONY BIOSCIENCES LLC | 8 | $134 |
| Philips North America LLC | 5 | $108 |
Products named: NUCALA, DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, Ohtuvayre, AIRSUPRA, ZEPBOUND, PURIFIED CORTROPHIN GEL.
Industry payments across NJ — which companies pay providers there.
